Similarweb Files 2025 Annual Report, Reinforcing Existing Financial Narrative

What happened

Similarweb has submitted its 2025 annual report on Form 20-F to the SEC, a routine regulatory step that provides audited financial data for the year ended December 31, 2025. The report likely confirms prior disclosures of ~15% revenue growth, net revenue retention around 98%, and positive but volatile free cash flow, as outlined in the DeepValue master report. Investors can now access detailed figures on key metrics such as remaining performance obligations, which grew 26% year-over-year to $267.6 million, and the multi-year contract mix at 58% of ARR. This filing does not introduce new operational surprises but underscores the company's ongoing challenges with GAAP profitability and dependence on large customers for growth. Management's strategic focus remains on scaling GenAI products and navigating competitive pressures while aiming for margin expansion.

Implication

The filing offers a comprehensive audit of Similarweb's 2025 performance, enabling deeper analysis of revenue durability, cost efficiency, and balance-sheet risks like the credit facility maturing in 2026. Key areas to monitor include net revenue retention trends, which softened to 98% in Q3 2025, and free cash flow sustainability amid volatile quarterly results. Since the DeepValue report already incorporates data through Q3 2025, the annual report is unlikely to alter the base case valuation of $9 per share, derived from mid-teens growth and improving margins. However, any unexpected disclosures on customer churn or GenAI adoption could affect the bear ($4.50) or bull ($11.50) scenarios. Overall, this event is procedural and reinforces the need for disciplined execution, but does not warrant a shift in the investment rating from POTENTIAL BUY.

Thesis delta

No material shift in the investment thesis is indicated by this filing, as it confirms financial data already reflected in prior reports and the DeepValue analysis. Investors should maintain focus on net revenue retention, free cash flow trends, and GenAI scaling as critical drivers, with the thesis remaining dependent on management delivering on 2025 guidance and stabilizing key metrics above 100% NRR.